Sanofi and GSK partner to develop Covid-19 vaccine

14 April 2020 (Last Updated April 14th, 2020 14:23)

Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.

While Sanofi and GSK are also working separately to enable vaccines for the viral infection, the latest alliance is intended to combine their respective technologies.

Read the full article here